So why wait
However, clinical decisions should be guided by comprehensive cardiovascular risk assessment (e.g., QRISK3) and adherence to NICE guideline NG238 for cardiovascular disease risk assessment and reduction, which provides clear guidance on lipid modification based on individual risk profiles
3 Being on long-term endocrine therapy (tamoxifen, anastrozole, letrozole, or exemestane) doesnt prevent you from taking Wegovy
These are the same active ingredients found in Ozempic, Wegovy, Mounjaro, and Zepbound, but they are prepared by licensed compounding pharmacies rather than the original manufacturers (Novo Nordisk and Eli Lilly)
Common adverse effects include: Nausea (reported by 30-40% of patients at the 2.4 mg dose) Vomiting Diarrhea Constipation Abdominal pain Decreased appetite These gastrointestinal symptoms are typically most pronounced during dose escalation and often improve with continued treatment